# Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

> **NCT03836690** · PHASE1 · UNKNOWN · sponsor: **University College, London** · enrollment: 18 (estimated)

## Conditions studied

- Lymphoma
- Leukemia
- Myeloma
- Myelodysplastic Syndromes
- Severe Aplastic Anemia
- Primary Immune Deficiency
- Graft Vs Host Disease

## Interventions

- **BIOLOGICAL:** CD62L- Tem

## Key facts

- **NCT ID:** NCT03836690
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-21
- **Primary completion:** 2022-07-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2019-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03836690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03836690, "Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03836690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*